Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
about
Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococciReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsInhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureusDouble-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicityRole of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureusBactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital.Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital.Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis.Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolatesCharacterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds.Teicoplanin stress-selected mutations increasing sigma(B) activity in Staphylococcus aureus.Infective endocarditis: a diagnostic and therapeutic challenge for the new millennium.CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Right-sided endocarditis caused by Staphylococcus aureus in drug abusers.In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganismsOverproduction of a 37-kilodalton cytoplasmic protein homologous to NAD+-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus.Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus.Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.Current perspectives on glycopeptide resistance.Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics.Presence of UDP-N-acetylmuramyl-hexapeptides and -heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin, or vancomycin.Cloning of the Staphylococcus aureus ddh gene encoding NAD+-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolateAntimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infectionsGlycopeptide resistant Staphylococcus.Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significanceThe new threats of Gram positive pathogens: re-emergence of things past.Glycopeptide antibiotics: back to the future.Effect of human serum on killing activity of vancomycin and teicoplanin against Staphylococcus aureus.Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complexComparative effect of protein binding on the killing activities of teicoplanin and vancomycin.Teicoplanin: 10 years of clinical experience.A closer look at vancomycin, teicoplanin, and antimicrobial resistance.Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method.
P2860
Q24519004-B4A0149B-93FC-4BEA-8AD0-A21F0F8867BEQ24646677-A48030DC-7FAA-47BB-81F5-19762B9D4FDDQ24679159-30211FB3-8E76-4F79-ABF3-3A8592D9DF14Q28326763-CBD3F5BA-3E39-4BF3-807B-12391A3F93DAQ33750776-32010C2C-0B04-45FC-B435-01F7DAD51CC6Q33756241-46BC72CC-B6F9-4DD5-8B1E-756DFF864C21Q33758399-93F24B1D-57EF-4B2F-A3F6-7146F251AFF0Q33965630-59C9030E-74B7-45FD-B8EC-B59F0A2CB374Q33968859-53A43E37-D003-4A3C-AFB7-AADC2164C033Q33978595-097EE2CA-61CF-45A9-975D-A456B1A13D85Q33978642-A51CC386-B015-42A0-9ACB-2667C2A39863Q33978671-08A99E48-13C9-43B3-84B7-B67B3EB54B03Q33982248-E9298AC8-E908-4646-ABCA-5CBBCCFE9123Q34014215-05F48252-D2D8-46A8-94DD-2B5FADB70B2EQ34537953-ABA0DF57-CEA1-47F6-9FDA-00A003429F8BQ34721614-A11D4966-A6C6-4697-AFFF-307B618255C8Q35014464-C708B543-7A1D-476A-A923-EDCBF8B71E42Q35023285-CFE8816B-F956-47E6-B889-6B698672285EQ35111909-43D3F2D7-96C3-4A06-91DD-1D629D4E31FAQ35120346-50DE4DB4-FC82-4BB8-8FC9-4B14B43A13E0Q35121917-A41EBAB9-C3FA-405A-B44F-7E3B00B92E3BQ35137758-BCB9FD70-ABF1-44B9-85A0-48BA21185B0AQ35138989-B121FAA4-6755-4C9F-841D-10709A33AF99Q35280233-0EF9C34E-BD68-48D5-A565-D1B97F6B8B4EQ35368590-614BA77C-2F81-470C-A041-2B7DA1D33F50Q35376362-BE1132E8-DAA2-42C3-BC84-54683CAAE87AQ35610665-007A34BC-AE53-4F11-B0CB-1821F2E68B8DQ35626765-94F46F4F-DEC2-41ED-9B93-442B587D381AQ35631929-13058E10-54C3-4252-9DBC-025274F1E9AEQ35826240-F0B91814-11AC-41C0-9DD2-4108A4C597D9Q35938608-54454D86-ADCB-4E5D-9B95-FD4467082145Q36692468-5DC4EC2C-611F-4162-8FED-B42F15E1806FQ37218104-9B06A0DD-7D70-45A5-8B2C-AEDE0BF5863BQ38239460-4CE4BC1B-1BBE-45F1-BDCC-490246658720Q39400073-03559EAE-A50A-4AD7-9018-3E7819047211Q39882528-C76E5DBE-CBBE-4DF2-A2EE-9B07E529DC78Q40284247-A579F6F2-0DA6-4041-8998-2420893AA2ACQ40495612-71BB15DA-3D78-4773-B468-C25CD82810E2Q41646436-B352D94A-DB9B-4D48-971E-EADB3152A926Q42169334-80B560EF-E479-4B5D-A3EB-160C9D7CF773
P2860
Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
@en
Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
@nl
type
label
Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
@en
Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
@nl
prefLabel
Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
@en
Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
@nl
P2093
P356
P1476
Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
@en
P2093
P304
P356
10.1093/INFDIS/162.1.103
P407
P577
1990-07-01T00:00:00Z